Related by context. All words. (Click for frequent words.) 72 introduced NEUGENE 70 siRNA therapeutic 69 ESPRIT therapy 69 siRNA delivery 69 Factor VIIa 68 liposomal formulation 68 Duchenne muscular dystrophy DMD 68 pharmacological chaperone 68 Locked Nucleic Acid LNA 68 oral prodrug 68 stable nucleic acid 68 antisense drug 68 HSP# inhibitor 67 proteasome inhibitor 67 ALN TTR# 67 Fc fusion protein 67 proprietary PEGylation 67 Angiocept 67 orally bioavailable 67 siRNA therapeutics 67 Nanobody ® 67 Fleximer 66 CBLC# 66 targeted radiotherapeutic 66 PDE4 inhibitor 66 IAP inhibitors 66 Symadex 66 personalized immunotherapy 66 CYT# potent vascular disrupting 66 JAK1 66 synthetic retinoid 66 Sphingomab 66 MEK inhibitor 66 targeting CD# 66 XmAb# 66 antisense oligonucleotide 66 novel peptide 66 PNP inhibitor 66 PEGylated 66 lipid nanoparticle 66 investigational humanized monoclonal antibody 65 humanized antibody 65 HCV protease inhibitor 65 dasatinib Sprycel 65 engineered RAP peptides 65 humanized monoclonal antibodies 65 delipidation 65 antisense oligonucleotides 65 AVI NEUGENE 65 Squalamine 65 PI3K inhibitor 65 NEUGENE 65 Xanafide 65 JAK inhibitors 65 cancer immunotherapies 65 HCV protease inhibitors 65 vivo validation 65 humanized antibodies 65 Onconase 65 Resten NG 65 therapeutic monoclonal antibody 65 small molecule tyrosine 65 JAK inhibitor 65 mda 7 65 JAK2 inhibitor 65 HCV protease 65 pan HDAC inhibitor 65 CORT # 65 DiLA2 65 dexpramipexole 65 short interfering RNA 65 AAV vector 65 RNAi therapeutic targeting 65 antisense 65 Guanilib 65 Locked Nucleic Acid 65 vascular disrupting agents 65 AtuRNAi 64 TLR9 agonist 64 vascular disrupting agent 64 Morpholino 64 bevacizumab Avastin ® 64 histone deacetylase inhibitors 64 XmAb 64 lentiviral vector 64 MEK inhibitors 64 immunomodulatory 64 aerosolized KL4 surfactant 64 Carfilzomib 64 preclinically 64 tyrosine kinase inhibitor 64 A3 adenosine receptor 64 selective androgen receptor modulator 64 small molecule defensin 64 HQK 64 HuLuc# 64 PRT# 64 systemic RNAi 64 Anavex #-# 64 HGS# 64 adenoviral 64 entinostat 64 BiTE 64 Interferon alpha 64 Nanobody 64 atacicept 64 antagomirs 64 selective inhibition 64 small molecule activators 64 IAP inhibitor 64 nucleoside analogues 64 ENMD # 64 receptor tyrosine kinase inhibitor 64 multi kinase inhibitor 64 vinca alkaloid 64 CEQ# 64 humanized anti 64 Transfection Reagent 64 IMA# 64 Hedgehog inhibitor 64 immune modulator 64 histone deacetylase inhibitor 64 antitumor 64 liposomal 64 PSMA ADC 64 OHR/AVR# 64 CGEN # 64 #beta HSD1 64 RNA interference RNAi 64 nanoviricides 63 familial amyloidotic polyneuropathy FAP 63 AKIP 63 immunotherapeutic vaccine 63 angiogenesis inhibition 63 RNA antagonists 63 Pertuzumab 63 SNALP technology 63 neuroprotectant 63 nucleoside analog 63 DermaVir 63 ON #.Na 63 CD# monoclonal antibody 63 anionic backbone 63 AAG geldanamycin analog 63 Gleevec resistant 63 novel therapeutic antibodies 63 IRX 2 63 virus AAV 63 Anticalin 63 Curaxin CBLC# 63 AEG# 63 THR beta agonist 63 Vascugel 63 molecularly targeted 63 iPSC 63 Curaxin 63 proteasome inhibitors 63 liposomal delivery 63 Thiarabine 63 anti CD3 antibody 63 depsipeptide 63 rFVIIIFc 63 selective androgen receptor modulators 63 anticancer therapies 63 Panzem 63 lipid nanoparticle LNP 63 Corgentin 63 Fibroblast Growth Factor Receptor 63 transcutaneous immunization TCI 63 Hsp# inhibition 63 anticancer agent 63 BRAF inhibitors 63 NovaBay Aganocide compounds 63 Tyrima 63 MT# MEDI 63 Enkephalin 63 TLR9 agonists 63 eniluracil 63 LNP formulations 63 kidney urologic 63 cetuximab Erbitux R 63 recombinant antibodies 63 DsiRNA 63 DepoVax TM 63 angiogenesis inhibitor 63 Epothilones 63 KL4 surfactant 63 Enzyme Replacement Therapy 63 rxRNA 63 Aviptadil 63 ProSavin 63 NEUGENE antisense 63 histone deacetylase HDAC inhibitor 63 NTDDS 63 polymerase inhibitor 63 UsiRNAs 63 isoform selective 63 FGFR 63 Factor Xa inhibitor 63 otelixizumab 63 tafamidis 63 YONDELIS 63 immune stimulatory 63 Ampligen ® 63 VitiGam 63 Aflibercept 63 mGluR2 NAM 63 TRX1 63 KineMed 63 NS#/#A protease 63 Celator 63 DermaVir Patch 63 metaglidasen 63 pertuzumab 63 LentiVector technology 63 deacetylase inhibitors 63 Stapled Peptide 63 antibody fragment 63 bioactive lipids 63 SARMs 63 chemotherapeutic drug 63 RECOTHROM R 62 PEGylation technology 62 Alfacell proprietary ribonuclease 62 buccal delivery 62 Pentraxin 2 62 immunotoxin 62 reversible inhibitor 62 siRNA compounds 62 LEX System 62 IgG1 antibody 62 INS# [001] 62 LHRH antagonists 62 ESBA# 62 ALN TTR 62 CA4P 62 ganetespib 62 2DG 62 flavopiridol 62 acetylcholinesterase AChE 62 PPMO 62 Sphingomab TM 62 chemically modified siRNA 62 Lpathomab 62 ATL# [001] 62 PORxin TM 62 Iluvien ® 62 BRAF inhibitor 62 histone deacetylase HDAC 62 Elvitegravir 62 HepDirect 62 histone deacetylase HDAC inhibitors 62 PEGylated interferon 62 EGF receptor 62 Aliskiren 62 Zenvia ™ 62 CCX# 62 LentiVector 62 AtuPLEX 62 Revimmune 62 sd rxRNA 62 Degarelix 62 metabonomics 62 antisense drugs 62 Bezielle 62 Intravenous CP 62 delivered RNAi therapeutic 62 MediVas 62 oncolytic virus 62 protein kinase inhibitor 62 antisense compounds 62 immune modulation 62 immunotherapeutics 62 gene silencing 62 OncoVEX 62 Anticalin ® 62 VEGF inhibitors 62 EndoTAG TM -1 62 cMET 62 Dasatinib 62 proprietary LNA 62 PKC# 62 virus HCV protease inhibitor 62 Anticalins R 62 Cylene 62 lumiliximab 62 PARP inhibition 62 Solazed TM 62 Receptos 62 drug conjugate 62 phase IIa clinical 62 obatoclax 62 lentiviral 62 trastuzumab DM1 T DM1 62 Vidofludimus 62 TG# [003] 62 virotherapy 62 multicenter Phase II 62 chimeric monoclonal antibody 62 CCR5 antagonist 62 p# inhibitor 62 Affibody 62 Cetrorelix 62 recombinant adeno associated 62 PEGylated Fab fragment 62 epothilone 62 allosteric modulation 62 triphendiol 62 orally administered inhibitor 62 siRNA binds 62 Homspera TM 62 pegylation 62 phage display 62 Traficet EN 62 Panzem R 62 DepoVax 62 Lixivaptan 62 MGd 62 SGLT2 inhibitors 62 antiangiogenesis 62 NEUGENE R 62 somatostatin analogue 62 antiangiogenic 62 gemcitabine Gemzar ® 62 Prodarsan ® 62 biologic therapeutics 62 SMaRT ™ 62 immunotherapeutic 62 Sorafenib 62 mdx mouse 62 OX1 62 MyVax R 62 Pervasis 62 tiapamil 62 bispecific antibody 62 nicotinic alpha 7 62 HTS assay 61 Phylomer ® 61 alkylating agent 61 erlotinib Tarceva ® 61 BCR ABL inhibitors 61 Preclinical studies suggest 61 prodrugs 61 midstage trials 61 ZFP TF 61 Sym# 61 systemic RNAi therapeutic 61 DOS# 61 non nucleoside 61 KNS # 61 kinase inhibitor 61 acetonide FA 61 immatics 61 Pagoclone 61 shRNA libraries 61 Plicera 61 inhibit metastasis 61 therapeutic monoclonal antibodies 61 silico prediction 61 non nucleoside HCV 61 CCR2 61 pegylated 61 tranilast 61 GW# [003] 61 Dicer Substrate Technology 61 ArQule Kinase Inhibitor Platform 61 reslizumab 61 thalidomide Thalomid 61 phase IIb clinical 61 beta 1a 61 anti angiogenic agent 61 histone deacetylase 61 MKC# MKC# PP 61 resolvins 61 TELINTRA 61 mertansine 61 ocular formulation 61 anticoagulant reversing agent 61 generation nucleoside analog 61 HDAC inhibition 61 GRNVAC1 61 lomitapide 61 Octreotide 61 vitro assay 61 MT#/MEDI-# 61 tyrosine kinase inhibitors 61 cancer immunotherapy 61 VEGF receptor 61 EndoTAG TM 61 mGluR5 antagonist 61 adult mesenchymal stem 61 Maxy G# 61 Tekmira LNP technology 61 ADP receptor antagonist 61 Scil Proteins 61 MDRNA proprietary 61 DXL# 61 vidofludimus 61 Talabostat 61 MMP inhibitors 61 imatinib Gleevec 61 Personalized Immunotherapy 61 anticancer therapeutics 61 immunological diseases 61 Bucindolol 61 SPC# [001] 61 ZFP Therapeutic 61 HCV NS5B polymerase 61 reverse vaccinology 61 GMX# 61 TRV# [001] 61 Blinatumomab 61 MAXY G# 61 RNAi therapeutic 61 Curaxins 61 ELACYT 61 myelofibrosis polycythemia vera 61 neurotrophic 61 ALN HTT 61 Radiation Therapy SIRT 61 Vascular Endothelial Growth 61 protein tyrosine phosphatase 1B 61 ALN PCS 61 Telatinib 61 inosine 61 gefitinib Iressa 61 anti CD3 61 pathophysiological effects 61 novel immunomodulatory 61 oral Janus kinase 61 TriRima 61 Ataluren 61 RNA antagonist 61 humanized monoclonal 61 HDAC inhibitors 61 pomalidomide 61 anti amnesic 61 trabectedin 61 PEGylation 61 Rasagiline 61 oral JAK1 61 Micromet BiTE 61 SNT MC# 61 antisense inhibitors 61 immunomodulation 61 LPA1 receptor 61 DFMO 61 peptide conjugated 61 Fenretinide 61 morpholino 61 nanoviricide 61 therapeutic modality 61 peptide antigens 61 Omacetaxine 61 Romidepsin 61 novel immunotherapeutic 61 TRO# 61 docetaxel Taxotere R 61 radezolid 61 elotuzumab 61 FOLOTYN ® 61 PNT# 61 small molecule agonists 61 LNPs 61 dSLIM 61 Lu AA# 61 orally dosed 61 anti fibrotic 61 mTOR inhibitor 61 γ secretase 61 Liprotamase 61 Phase IIb clinical trials 61 ZFN technology 61 NPC 1C 61 Novosom 61 ANTISENILIN ® 61 inhaled formulation 61 HGS ETR1 mapatumumab 61 HuMax EGFr 61 Cytolin ® 61 Aptamer 61 fosbretabulin 61 teplizumab 61 enzyme inhibitor 61 peroxisome proliferator activated 61 tkRNAi 61 sodium glucose cotransporter 61 small molecule 61 highly selective endothelin 61 Ceflatonin R 61 KL4 Surfactant 61 mTOR inhibitors 61 Unit Dose Budesonide 61 docetaxel Taxotere ® 61 Intravesical 61 TRIOLEX 61 CCR1 61 cediranib 61 oncolytic 61 EGS# 61 targeted antifolate 61 Immunotherapeutic 61 REG1 61 Aurora kinase 61 alagebrium 61 fibrotic disease 61 Anticalin R 61 transgenic mouse models 61 Phase #b/#a clinical 61 Posiphen 60 PEG SN# 60 Amigal 60 anticancer therapy 60 P#X# 60 DCVax R 60 Cyclosert 60 ADAMTS# 60 Nexavar sorafenib 60 evaluating tivozanib 60 MTP inhibitor 60 potently inhibit 60 HepDirect R 60 Temsirolimus 60 RNA silencing 60 cilengitide 60 inhibitor RG# 60 immune modulating 60 TLR agonists 60 Campath alemtuzumab 60 antisense inhibitor 60 BMS # 60 PI3K/Akt pathway inhibitor 60 volociximab 60 Chemokine Receptor 60 PARP inhibitor 60 retinal dystrophies 60 selective antagonist 60 immunotoxins 60 FoldRx 60 RNA interference RNAi therapeutics 60 Nanobodies 60 Safinamide 60 Anticalins ® 60 novel VDA molecule 60 Viprovex TM 60 cathepsin K inhibitor 60 RhuDex R 60 antitumoral 60 relapsing multiple sclerosis 60 Oligonucleotide 60 BHT DNA 60 Androxal TM 60 epothilones 60 glucagon receptor 60 DHFR 60 Aganocide 60 ddRNAi 60 rHuPH# recombinant human 60 Diabetic Macular Edema DME 60 anti mitotic 60 rhMBL 60 adenoviral vectors 60 Photodynamic therapy PDT 60 radiation sensitizer 60 Tekmira SNALP technology 60 metabolite identification 60 IFN alpha 60 Protein Kinase C 60 Azacitidine 60 NXL# 60 Fleximer R 60 novel RNAi therapeutics 60 Ridaforolimus 60 Synavive 60 Fx #A 60 Nautilus Biotech 60 SERMs 60 OncoVEX GM CSF 60 NOD mouse 60 ALK inhibitor 60 Aurora kinase inhibitor 60 Preclinical studies 60 RONDEL ™ 60 Lodamin 60 antitumour 60 Archexin 60 selective kinase inhibitor 60 predictive biomarkers 60 Phase 1a clinical 60 Abatacept 60 erlotinib Tarceva 60 corticosteroid dexamethasone 60 tolerogenic 60 vivo electroporation 60 DermaPrep 60 integrase inhibitor 60 receptor modulators 60 antibody MAb 60 Tumor Necrosis Factor 60 TLR Therapeutics 60 RONDEL TM 60 NV1FGF 60 XmAb ™ 60 Affilin ® 60 MYDICAR ® 60 Tarvacin 60 INGAP 60 ALN VSP 60 Vilazodone 60 eligen R technology 60 GeneICE 60 Tesetaxel 60 IMC #B 60 Deforolimus 60 #ME# 60 mitotic kinesin 60 diarrhea predominant irritable 60 pharmacodynamic biomarkers 60 chemokine receptor 60 vemurafenib 60 personalized cellular immunotherapy 60 immunoregulation 60 partial agonist 60 Aurora kinase inhibitors 60 selective adenosine 60 Gleevec imatinib mesylate 60 Liposomal 60 bortezomib Velcade 60 generation antisense 60 Fc receptor 60 VA# [002] 60 Factor VEGF 60 polymerase inhibitors 60 Antisense 60 Tarvacin TM 60 Lauriad R 60 Annamycin 60 PD LID 60 immune modulatory 60 investigational therapies 60 hedgehog pathway 60 olaparib 60 Rigel R# 60 TACI Ig 60 OMP #R# 60 Adenosine Therapeutics 60 Alnylam RNAi 60 GGF2 60 small molecule inhibitors 60 potentiator 60 Phase Ib study 60 NITD# 60 dasatinib Sprycel ® 60 NS4A 60 insulin sensitizer 60 HDACi 60 Hsp# inhibitors 60 Nasdaq CGEN 60 TLK# 60 Avian Transgenic Technology 60 Bevasiranib 60 FLT3 60 taxane derivative 60 GTC recombinant human 60 humanised monoclonal antibody 60 Tyrosine Kinase Inhibitor 60 cyclosporin 60 anticancer agents 60 LEAPS TM 60 antifibrotic 60 JAK3 60 lipid nanoparticles 60 Gefitinib 60 Allovectin 7 60 Ophthotech 60 ATTR CM 60 antibody humanization 60 Phase #/#a 60 ulimorelin 60 Smac mimetics 60 idarubicin 60 small molecule PEGylation 60 intracellular signaling pathways 60 Litx 60 Panzem NCD 60 PARP inhibitors 60 rxRNA compounds 60 Bioral ® 60 allosteric modulator 60 POTELLIGENT ® 60 Epratuzumab 60 AMPK activators 60 Vaccinex 60 Mipomersen 60 PI3K inhibitors 60 SinuNase ™ 60 Prodarsan R 60 Pancreate 60 Bioral 60 riociguat 60 neuroprotective properties 60 PARI Pharma GmbH 60 standard chemotherapy regimen 60 Microplasmin 60 intravesical instillation 60 oligonucleotide therapeutics 60 CRLX# 60 Cytolin R 60 ARIKACE ™ 60 Janus kinase 60 Spiegelmers R 60 lipidoid 60 Pimavanserin 60 SOD1 gene 60 Solorel TM 60 leukotriene pathway 60 TLR8 60 Selective Electrochemical Tumor Ablation 60 phosphate S1P 60 vascular disrupting 60 multitargeted 60 PML RARA 60 ZFN 60 systemic fungal infections 60 potent anti angiogenic 60 PSN# [001] 60 Proxinium TM 60 Dalbavancin 60 Exherin TM 60 kinase inhibitors 60 antigen sparing 60 trodusquemine 60 peripherally acting 60 gamma secretase inhibitors 60 Enzastaurin 60 ATL# [002] 60 Anticalins 60 tumor specific antigen 60 oral antiviral 60 neuronal nicotinic receptor NNR 60 SNALP 60 Cyclosert TM 60 anti tubercular 60 rHuPH# 60 proteasome inhibitor bortezomib 59 DuraSite 59 Etubics 59 Flt3 59 URG# 59 Bicifadine 59 biodegradable implant 59 cellular immunotherapy 59 ribonuclease 59 PrevOnco 59 interferon IFN 59 hormone LHRH antagonist 59 RhuDex ® 59 Trofex 59 Hedgehog signaling pathway 59 splice variants 59 Metallophile ™ Technology 59 canagliflozin 59 CDP# 59 echinocandin 59 immunomodulator 59 investigational pan BCR 59 Intravail ® 59 immunosuppressant drug 59 Sudhir Agrawal D.Phil 59 OXIGON TM 59 HuMax CD# 59 delta isoform 59 tezampanel 59 Voreloxin 59 Quinamed 59 Janus Kinase 59 potent inhibition 59 camptothecin 59 bifunctional 59 GIPET 59 Trophos 59 molecular biomarkers 59 canakinumab 59 TBC# 59 viral kinetics 59 TOCOSOL 59 CCR9 antagonist 59 Lisofylline 59 Isis antisense 59 product platforms AZX# 59 receptor inhibitor 59 Olaparib 59 Fludara ® 59 EGFR inhibitors 59 NS5A 59 synthetic peptide 59 geldanamycin 59 RNAi compounds 59 novel topoisomerase 59 BAY #-# 59 selective orally bioavailable 59 DACH platinum 59 indibulin 59 AFFITOME R 59 INCB# [001] 59 mGlu2 3 59 zanolimumab 59 Tumour Vascular Disrupting Agent 59 PTC# 59 lipid particles 59 topoisomerase 59 ProSanos 59 Mitoxantrone 59 OMP #M# 59 Eligen ® Technology 59 antifolate 59 PEGylated interferon beta 1a 59 DepoFoam 59 imatinib Gleevec ® 59 Desmoteplase 59 fusion proteins 59 subtype selective 59 protein CETP 59 biomarker identification 59 epigenetic therapies 59 BNC# 59 specific lectin receptors 59 myeloproliferative disorders 59 Annexin A5 59 selective modulator 59 velafermin 59 mRNA antagonists 59 epithelial tumors 59 LymphoStat B TM 59 molecular imaging radiopharmaceutical 59 Investigational eFlow Nebulizer System 59 Peptidomics 59 cytostatic 59 Altastaph 59 HDL Selective Delipidation 59 constipation predominant irritable bowel 59 visilizumab 59 EZN 59 ZFP Therapeutics 59 nanomedicines 59 Aplidin 59 Onconova 59 Glybera 59 phosphatidylserine PS targeting 59 DPX Survivac 59 Affinitak 59 signal transduction inhibitor 59 DGAT 59 gamma secretase inhibitor 59 nucleotide analogs 59 PHX# 59 anti CD3 monoclonal 59 Eg5 59 HyACT 59 carbohydrate compounds 59 Abiraterone 59 intranasal formulation 59 biased ligand 59 luteinizing hormone releasing 59 BiTE R 59 ProMune 59 GSK# [002] 59 Bruton tyrosine kinase 59 Azedra 59 SERCA2a 59 Eculizumab 59 Bryostatin 59 Bafetinib 59 ATL/TV# 59 CTAP# Capsules 59 experimental autoimmune encephalomyelitis 59 nitric oxide donating 59 antibody fragment therapeutics 59 Tezampanel 59 rAAV 59 endosomal release 59 receptor monoclonal antibody 59 gene therapy 59 NexACT 59 GRN# 59 FK# 59 nonviral 59 bispecific 59 amikacin 59 OMNARIS HFA 59 reversible inhibitors 59 selective estrogen receptor modulator 59 JAK2 inhibitors 59 Cintredekin Besudotox 59 selective inhibitors 59 telomerase activator 59 phase Ib clinical 59 drug zotarolimus 59 ANAVEX #-# [001] 59 developing Bicifadine serotonin 59 renin inhibitors 59 tremelimumab 59 next generation URAT1 59 PEGylated anti 59 T#I [002] 59 JAK3 inhibitor 59 nucleotide analog 59 thiazolides 59 busulfan 59 etanercept Enbrel 59 cyclodextrin containing polymers 59 immunomodulatory therapy 59 small molecule thrombopoietin 59 TKM ApoB 59 trastuzumab Herceptin 59 subcutaneously administered 59 tumor antigen 59 nitric oxide donating prostaglandin 59 SGS# 59 Sapacitabine 59 Aurora Kinase 59 potent cytotoxic 59 cannabinor 59 TriGrid ™ 59 Myolimus 59 AMPAKINE 59 potent inhibitors 59 preclinical efficacy 59 CD4 monoclonal antibody 59 Accelerated Intelligent 59 Cannabinor 59 oral ghrelin agonist 59 castrate resistant prostate cancer 59 LY# [003] 59 siRNA molecules 59 MAGE A3 ASCI 59 NMDA antagonist 59 iSONEP 59 FGFR1 59 GLP toxicology studies 59 Santaris 59 Onalta 59 Hemopurifier ® 59 G Protein Coupled 59 Morquio 59 chemotherapeutics 59 phase IIb trial 59 Factor Receptor 59 MVA BN R 59 edifoligide 59 novel synthetic peptide 59 haplotyping 59 vapreotide acetate 59 Anidulafungin 59 VRX# [002] 59 PDE# inhibitors 59 S#P# 59 oral Azacitidine 59 platinum chemotherapeutic 59 teriflunomide 59 glycogen synthase kinase 59 antiproliferative effects 59 ibudilast 59 BioSilicon 59 maturation inhibitor 59 acadesine 59 eTag assays 59 MET VEGFR2 59 MIS# 59 selective relaxant 59 SCH # 59 single stranded oligonucleotides 59 elvucitabine 59 OXIGON 59 proprietary transdermal 59 KRN# 59 ZFNs 59 Aganocide ® 59 ANG# 59 massively parallel sequencing 59 anti infective treatments 59 Syntonix 59 systemically administered 59 oxidative stress inducer 59 investigational HCV polymerase 59 selective immunoproteasome inhibitor 59 TriGrid 59 Interferon beta 59 NP2 Enkephalin 59 Bavarian Nordic patented 59 DepoVax ™ 59 Pyridorin 59 alfa interferon 59 mediated apoptosis 59 PSN# [002] 59 DNAi 59 chimeric antibodies 59 adenovector 59 highly selective inhibitor